Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2021 06:01 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference

RANCHO CUCAMONGA, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, V.P of Corporate Communications and...
December 29, 2020 06:00 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Announces Approval for Glucagon for Injection Kit, 1mg

RANCHO CUCAMONGA, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has approved its Abbreviated...
November 06, 2020 06:50 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020

RANCHO CUCAMONGA, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended September...
October 29, 2020 16:05 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2020

RANCHO CUCAMONGA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its third quarter of 2020 ended...
October 06, 2020 06:00 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection

RANCHO CUCAMONGA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s...
September 03, 2020 16:05 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference

RANCHO CUCAMONGA, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate...
August 06, 2020 16:05 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020

RANCHO CUCAMONGA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended June 30,...
July 30, 2020 16:05 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020

RANCHO CUCAMONGA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2020 ended June...
June 19, 2020 06:05 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference

RANCHO CUCAMONGA, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate...
June 12, 2020 06:30 ET | Source: Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference

RANCHO CUCAMONGA, Calif., June 12, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate...